In summary, our findings highlight the potential significance of CSH1 in the regulation of Bregs and its implications in BLCA progression for the first time and targeting CSH1 in Bregs seems a promising treatment strategy for BLCA cases. The gene discussed is CSH1; the disease is bladder transitional cell carcinoma.